Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LHPP expression in triple-negative breast cancer promotes tumor growth and metastasis by modulating the tumor microenvironment

ABSTRACT: Triple-negative breast cancer (TNBC) is a highly aggressive and metastatic form of breast cancer that lacks an effective targeted therapy. To identify potential therapeutic targets, we investigated the phosphohistidine phosphatase, LHPP, which has been implicated in the development of several types of cancer. However, the full significance of LHPP in cancer progression remains unclear due to our limited understanding of its molecular mechanism. We found that levels of the LHPP phosphohistidine phosphatase were significantly increased in human breast cancer patients compared to normal adjacent tissues, with the highest levels in the TNBC subtype. When LHPP was knocked out in the MDA-MB-231 human TNBC cell line, cell proliferation, wound healing capacity, and invasion were significantly reduced. However, LHPP knockout in TNBC cells did not significantly affect overall phosphohistidine protein levels. Interestingly, LHPP knockout in MDA-MB-231 cells delayed tumor growth and reduced metastasis when orthotopically transplanted into mouse mammary glands. To investigate LHPP’s role in breast cancer progression, we used next-generation sequencing and proximity-labeling proteomics, and found that LHPP regulates gene expression in chemokine-mediated signaling and actin cytoskeleton organization. Depletion of LHPP reduced the presence of tumor-infiltrating macrophages in mouse xenografts. Our results support a tumor promoter role for LHPP phosphohistidine phosphatase in MDA-MB-231TNBC cells and suggest that targeting LHPP phosphatase could be a potential therapeutic strategy for TNBC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE281450 | GEO | 2025/11/07

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Effect of silencing of DEPDC1 on gene expression in MDA-MB 231 TNBC cell line

Project description:DEPDC1 supports tumor growth, migration and metastases formation. To investigate what is the gene expression network regulated by DEPDC1, we silenced its expression in MDA-MB-231 Triple Negative Breast Cancer (TNBC) cell line. We then performed gene expression profiling analysis using data obtained from RNA-seq of MDA-MB 231.

2025-10-18 | GSE281411 | GEO

Role of SIPA1 in chemotherapy resistance in breast cancer cells

Project description:SIPA1 is a potential transcriptional modulator of tumor metastasis and recurrence. Here we showed that the breast cancer patients with higher SIPA1 expression have a higher relapse rate and worse prognosis, especially for triple-negative breast cancer (TNBC) patients. Moreover, SIPA1 expression was found positively correlated with relapse of breast cancer patients receiving adjuvant chemotherapy. In a TNBC cell line MDA-MB-231, we identified the possible tumorigenesis and metastasis processes regulated by SIPA1, and demonstrated that SIPA1 promoted cancer stem-like feature to form tumourspheres. Tumoursphere-formed MDA-MB-231 cells were shown to be resistant to epirubicin. Then we confirmed that SIPA1 could particularly activate the CD44 promoter and upregulate CD44 expression. Furthermore, SIPA1 could promote ABCB1 expression and strengthen chemoresistance of MDA-MB-231 cells to epirubicin. In conclusion, SIPA1 is a risk factor for highly-relapse in TNBC patients and a transcriptional regulator to maintain cancer stem-like features and promote chemoresistance in breast cancer cells.

2018-12-25 | GSE124344 | GEO

c-Src functionality controls self-renewal, tumorigenicity and glucose metabolism in breast cancer stem cells

Project description:Deregulation of Src kinases is associated with cancer. We previously showed that SrcDN conditional expression in MCF7 cells diminished tumorigenesis and causes tumor regression in mice. However, it remained unclear whether SrcDN affected breast cancer stem cell functionality or it reduced tumor mass. Here, we address this question by isolating an enriched population of BCSCs (ESA+-CD44+-CD24-) and the tumor-differentiated cells (ESA+-CD44+-CD24+) from MCF7-Tet-On-SrcDN. ESA+-CD44+-CD24- grew in suspension forming mammospheres, and producing tumors in nude mice, while ESA+-CD44+-CD24+ were poorly/non-tumorigenic. Doxycycline-induction of SrcDN inhibited BCSC tumorigenesis, selfrenewal, and stem-cell markers expression. SrcDN significantly inhibited SFE, and stem-cell markers expression in triple-negative breast cancer (TNBC) MDA-MB-231 and SUM159PT cells. Inducible depletion of c-Src caused similar effects in MDA-MB-231 cells. In MCF7-Tet-On-SrcDN derived mammospheres SrcDN-induction inhibited expression, and activity of hexokinase, pyruvate kinase and lactate dehydrogenase, resulting in diminished glucose consumption and lactate production, which restricted Warburg effect. Thus, c-Src functionality is important for breast cancer stem cell maintenance and renewal, tumorigenicity, and stem cell transcription factor expression, effects linked to glucose metabolism reduction.

2020-07-23 | PXD017789 | Pride

ABCG8-mediated sterol efflux increases cancer cell progression through LRP6/Wnt/beta-catenin signaling pathway in radiotherapy-resistant triple negative breast cancer cells (RT-R-TNBC), RT-R-MDA-MB-231

Project description:ATP-binding cassette (ABC) transporters are known to be increased in various tumor cells, including breast cancer. They are responsible for mediating drug resistance, leading to treatment failure. In the present study, gene expression array analysis revealed that among ABC transporter subtypes, ABCG8 was most increased in radiotherapy-resistant triple negative breast cancer (RT-R-TNBC) compared to TNBC. ABCG8 is known to be involved in sterol efflux, but its role in cancer is not well known. Therefore, we investigated the effect of ABCG8 on tumor progression in RT-R-TNBC. RT-R-MDA-MB-231 exhibited increased cholesterol levels in both cells and surrounding media by inducing SREBP1 and FASN. ABCG8 siRNA increased intracellular cholesterol but decreased media cholesterol, indicating an accumulation of cholesterol inside cells. Additionally, RT-R-MDA-MB-231 showed increased levels of β-catenin, which was significantly reduced by ABCG8 knockdown. Moreover, ABCG8 knockdown led to cell cycle arrest in the G2/M phase by reducing PLK1 and Cyclin B1. RT-R-MDA-MB-231 also exhibited increased phosphor-LRP6 and LRP6 levels, which were decreased by ABCG8 siRNA. Interestingly, LRP6 siRNA decreased β-catenin, PLK1, and Cyclin B1. In addition, feedback mechanisms such as LXR and IDOL were decreased in RT-R-MDA-MB-231 cells. This study suggests for the first time the role of ABCG8 and the cholesterol exported by ABCG8, not inside the cells, affects cancer progression through the LRP6/Wnt/beta-catenin signaling pathway in RT-R-TNBC. The regulation of this pathway may offer a potential therapeutic strategy for treating RT-R-TNBC.

2025-02-01 | GSE287883 | GEO

Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing

Project description:Adipocyte was found play a pivotal role in tumorgenesis, progression and metastasis in breast cancer. However, affection of adipocyte on gene expression profile in triple-negative breast cancer (TNBC) is still not clear. In the present study, firstly we reported the gene expression profiles of TNBC regulated by human adipocytes using NGS. TNBC cell MDA-MB-231 was used in this study. MDA-MB-231 cells were treated with medium derived from adipocytes culture supernatants. Using two different RNA libraries, we sequenced the complete transcriptome(including mRNA, lncRNA, circleRNA and small RNA) of MDA-MB-231 treated with medium derived from adipocytes culture supernatants.

2018-09-04 | GSE119377 | GEO

Reduced JAG1 expression through miR-200 overexpression or Crispr-Cas mediated knockout impairs TNBC growth and metastasis.

Project description:Studies from our lab and others demonstrated that increasing miR-200 expression in TNBC cell lines reduced proliferation and invasion in vitro and tumor growth and metastasis in vivo. However, the mechanisms through which miR-200s suppress TNBC growth and metastasis remains incompletely characterized. In this study, we found that overexpression of miR-200s in MDA-MB-231 and MDA-MB-436 cells significantly reduced the expression of several Notched-Jagged genes including JAG1. To further investigate the importance of JAG1, JAG1 was knocked out using Crispr-Cas in MDA-MB-231 cells which express high endogenous JAG1. Loss of JAG1 in MDA-MB-231 cells significantly reduced proliferation and invasion as well as increasing apoptosis in vitro. Moreover, loss of JAG1 delayed mammary tumor onset, mammary tumor growth rate and metastatic dissemination in vivo. RNA sequencing of control and MDA-231JAG1KO tumors revealed that knocking out JAG1 altered the expression of genes associated with the extracellular matrix, angiogenesis, and epithelial to mesenchymal transition. These results imply that miR-200s may mediate some of their anti-tumor actions through reducing JAG1 expression. In addition, the loss of JAG1 dramatically suppressed TNBC growth and metastasis thus suggesting that agents targeting JAG1 should be further evaluated as a therapeutic strategy for TNBC.

2025-05-05 | GSE288207 | GEO

Effect of silencing of p53 on gene expression in MDA-MB 231 TNBC cell line. [sip53]

Project description:Mutant p53 can acquires oncogenic properties supporting tumor growth, metastases and chemoresistance, by reprogramming cancer cell transcriptome, proteome and metabolome. To investigate what is the gene expression network regulated by mutant p53, we silenced its expression in MDA-MB-231 Triple Negative Breast Cancer (TNBC) cell line. We then performed gene expression profiling analysis using data obtained from RNA-seq of MDA-MB 231.

2023-10-06 | GSE214493 | GEO

Overexpression of miR-200c/141 and miR-200b/200a/429 in MDA-MB-436 cells

Project description:We previously showed that overexpression of the miR-200c/141 cluster in the TNBC cell line MDA-MB-231 significantly reduced proliferation and invasion in vitro and tumor growth and metastasis in vivo. To confirm the effects of miR-200s in another TNBC cell line, MDA-MB-436 cells were created to overexpress both the miR-200c/141 cluster and the miR-200b/200a/429 cluster.

2025-08-31 | GSE262478 | GEO

Tang2019 - Pharmacology modelling of AURKB and ZAK interaction in TNBC

Project description:Aurora Kinase B and ZAK interaction model Equivalent of the stochastic model used in "Network pharmacology model predicts combined Aurora B and ZAK inhibition in MDA-MB-231 breast cancer cells" by Tang et. al. 2018. The only difference is cell division and partitioning of the components, which are available in the original model for SGNS2.

2024-09-02 | BIOMD0000000940 | BioModels

Adrenergic Signaling and Proteomic Responses in Breast Cancer Spheroids: Implications for Tumor Microenvironment and Therapeutic Strategies

Project description:Breast cancer, a global health challenge, exhibits molecular heterogeneity and complex interactions with the tumor microenvironment. We investigated adrenergic modulation in breast cancer spheroids, differentiating between basal-like (MDA-MB-231 and BT549) and luminal-like (T47D and MCF-7) subtypes. Noradrenalin reduced MDA-MB-231 spheroid size, reversed by propranolol, suggesting therapeutic potential. Luminal-like spheroids displayed subtler responses. Proteomic analysis revealed subtype-specific alterations, with TP53 as a consistent regulator affected by noradrenalin. Our study highlights subtype-dependent adrenergic signaling in breast cancer, providing insights for targeted therapies.

2025-10-13 | PXD046841 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data